Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation
- PMID: 12359199
- DOI: 10.1053/ejso.2002.1279
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation
Abstract
Aim: Women with a proven BRCA1 or BRCA2 germ-line mutation or with a 50% risk of carrying the mutation, have an increased risk of breast cancer. Regular surveillance, chemoprevention or prophylactic mastectomy (PM) are options to detect breast cancer at an early stage or to reduce the risk. We describe the management of women who have opted for PM, the postoperative complications of PM, especially in combination with immediate breast reconstruction (IBR), and the oncological follow-up.
Methods: The medical records of all women who underwent a PM from December 1993 to December 1999 have been reviewed with respect to management, patient characteristics, complications and oncological follow-up.
Results: During the study period 112 women with a median age of 38.8 years opted for a PM: 76 were germline mutation carriers. After PM, 79 women without breast or ovarian cancer in their medical history, were free of disease after 2.5 years (median). Before PM, 29 women had been treated for breast cancer, 3.9 years (median) previously; 5 of these women had developed metastatic disease by the last consultation. Before PM, 2 patients had been treated for DCIS and 2 patients for ovarian cancer. Four DCIS were found; none of these women had evidence of disease 4.0 years (median) after PM. In 59 women laparoscopic prophylactic bilateral oophorectomy (PBO) was performed; 36 simultaneously with PM and 23 separately. A total of 103 women (92%) opted for IBR. After PM, the complication rate for IBR was 21%: 11% within 6 weeks and 10% at long-term follow-up (median 3.5) after PM, including the removal of 10 prostheses.
Conclusions: Women with an increased risk of breast cancer due to a genetic predisposition should be adequately informed about the different treatment options in the setting of a multidisciplinary approach. PM can simultaneously be combined with PBO and IBR. IBR can facilitate the decision to undergo a PM. PM followed by IBR has an acceptable complication rate.
Similar articles
-
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.Ann Surg Oncol. 2007 Dec;14(12):3335-44. doi: 10.1245/s10434-007-9449-x. Epub 2007 May 31. Ann Surg Oncol. 2007. PMID: 17541692 Free PMC article.
-
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145
-
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.Lancet. 2000 Jun 10;355(9220):2015-20. doi: 10.1016/s0140-6736(00)02347-3. Lancet. 2000. PMID: 10885351
-
Prophylactic surgery for women at high risk for breast cancer.Clin Breast Cancer. 2000 Jul;1(2):127-34; discussion 135. doi: 10.3816/cbc.2000.n.011. Clin Breast Cancer. 2000. PMID: 11899651 Review.
-
Breast cancer treatment in mutation carriers: surgical treatment.Minerva Ginecol. 2016 Oct;68(5):548-56. Epub 2016 Jan 28. Minerva Ginecol. 2016. PMID: 26822896 Review.
Cited by
-
Clinical genetics in breast cancer.J Surg Oncol. 2024 Jul;130(1):16-22. doi: 10.1002/jso.27630. Epub 2024 Apr 1. J Surg Oncol. 2024. PMID: 38557982 Free PMC article. Review.
-
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.Ann Surg Oncol. 2007 Dec;14(12):3335-44. doi: 10.1245/s10434-007-9449-x. Epub 2007 May 31. Ann Surg Oncol. 2007. PMID: 17541692 Free PMC article.
-
The role of prophylactic surgery in cancer prevention.World J Surg. 2007 Mar;31(3):450-64. doi: 10.1007/s00268-006-0616-1. World J Surg. 2007. PMID: 17308850 Review.
-
Mastectomy with immediate breast reconstruction: Results of a mono-centric 4-years cohort.Ann Med Surg (Lond). 2020 Dec 31;61:172-179. doi: 10.1016/j.amsu.2020.12.033. eCollection 2021 Jan. Ann Med Surg (Lond). 2020. PMID: 33437474 Free PMC article.
-
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.J Natl Cancer Inst. 2014 Nov 30;107(1):380. doi: 10.1093/jnci/dju380. Print 2015 Jan. J Natl Cancer Inst. 2014. PMID: 25435542 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous